Related Experiment Video

Updated: Jul 7, 2026

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

[Anti-angiogenic therapy in ocular disease--current and future strategies]

H Agostini1, N Feltgen, L Hansen

  • 1Universitäts-Augenklinik Freiburg. hansjuergen.agostini@uniklinik-freiburg.de

Klinische Monatsblatter Fur Augenheilkunde
|February 1, 2008
PubMed

Insights

Angioinhibitory strategies, initially from cancer therapy, are revolutionizing eye disease treatment. These therapies show promise for retinal conditions and may extend to corneal disorders involving new blood vessel growth.

Area of Science:

  • Ophthalmology
  • Oncology
  • Angiogenesis Inhibition

Context:

  • Therapeutic concepts from oncology have been adapted for ophthalmology.
  • Angioinhibitory strategies are now standard for retinal diseases such as age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion.

Purpose:

  • To provide a concise overview of current angioinhibitory options investigated in clinical trials for ophthalmic disorders.

Summary:

  • This review focuses on angioinhibitory strategies, highlighting their successful application in retinal diseases.
  • It explores the potential of these therapies for corneal disorders characterized by lymph- or angiogenesis.

Impact:

  • Angioinhibitory strategies have significantly altered the treatment landscape for major retinal diseases.
  • Future applications may expand to include corneal conditions, offering new therapeutic avenues.

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...